key: cord-0716103-vlbvp0ff
authors: Allgood, Sarah; Peters, Jessica; Benson, Andrew; Maragos, Carol; McIltrot, Kimberly; Slater, Tammy; Akst, Lee; Best, Simon R.; Galiatsatos, Panagis; Brodsky, Martin B.; Brenner, Michael J.; Pandian, Vinciya
title: Acquired laryngeal and subglottic stenosis following COVID‐19—Preparing for the coming deluge
date: 2021-08-08
journal: J Clin Nurs
DOI: 10.1111/jocn.15992
sha: 9b913040e61f2443add5656b72cdacdfb4243bb5
doc_id: 716103
cord_uid: vlbvp0ff

nan

Many individuals are initially asymptomatic or have only mild symptoms for weeks to months, as the stenosis insidiously progresses.

Inspiratory stridor is the most common presenting symptom, however, dyspnoea, dry cough, dysphagia, although some patients present with wheezing or a history of recurrent bronchitis (Shinn et al., 2019) . Tracheal stenosis is often misdiagnosed given similar presentations to asthma and other respiratory-related conditions. This possible confusion underscores the importance of obtaining a thorough medical history, including history of endotracheal intubation.

The severity of tracheal stenosis is determined via laryngoscopy and can be staged based on the length, location and extent of obstruction ( Figure 1 ). Staging has implication for both management and prognosis. The McCaffrey staging system classifies stenosis based on length and location of the stenosis (Table 1 ). In contrast, the Cotton-Meyer system of staging classifies stenosis severity based on the diameter of the remaining airway in correlation with the diameter of tracheal tubes, ranging from a Stage I classification for less than 70% obstruction to a Stage IV classification if there is 100% obstruction (Cotton, 1984; Myer et al., 1994) (Figure 2 ).

The best studied approach to medical management of LTS is steroid injection. Protocols for serial steroid injections vary but most often involve multiple rounds of the synthetic glucocorticoid triamcinolone 40 mg/dl injected directly into the stenosis under direct visualisation, typically four injections spaced 3 to 6 weeks apart.

These injections are usually performed while awake, using officebased laryngoscopy, and are very well-tolerated. This approach provides comparable improvements in peak expiratory flow compared to endoscopic dilation. Using steroidal injection as adjuvant therapy after dilation also can provide benefits, improving the inter-dilation interval compared to dilation alone.

Whereas steroid injections have a more preventative and temporising role in the management of LTS, surgery is the mainstay of treatment for severe cases. The two main types of surgery are categorised as endoscopic (focused largely on dilation with or without laser resection) and open (cricotracheal resection when stenosis involves cricoid cartilage, and tracheal resection with reconstruction when stenosis involves only a segment of the trachea). Endoscopic treatment is most commonly performed for idiopathic subglottic stenosis but may also have a role for post-intubation stenosis and offers minimal morbidity with good functional outcomes-however, stenoses are often recurrent and repeated dilations may be required.

When injury extends beyond mucosal surfaces to include damage to the cartilage framework of the larynx or trachea-as is often the cause with intubation-related LTS-open surgeries are often required. Surgical outcomes are more favourable for isolated tracheal resection, often involving distal stenoses; improvement is less consistent when cricotracheal resection is required, as with stenoses involving the larynx. Although open surgeries often allow for decannulation, repeated procedures may be necessary and voice may be negatively impacted. Furthermore, decannulation is not always achievable. As surgical management evolves, there may be a growing role for strategies that aim to modulate biology of the healing wound, such as endoscopic scar resection with skin-graft resurfacing of the stenotic area and tissue engineering approaches to tracheal replacement and transplantation.

LTS often has deleterious effects on physical, psychological and emotional quality of life, and treatment can help to alleviate these untoward effects. Online support groups exist, which can help reduce disease-specific anxiety and inform treatment decision-making.

In addition to the anticipated rise in prevalence of LTS associated with the pandemic, patients who already had LTS before COVID-19 are susceptible to amplified psychosocial stressors in relation to COVID-19-they may struggle with access to necessary care, given constraints on resources; stenosis-related cough and dyspnoea may cause them to be ostracised by individuals, healthcare professionals or members of the public, who mistakenly assume that individual with LTS have COVID-19, and fears of contracting COVID-19 themselves, which is a legitimate concern since COVID-19 can make a baseline tenuous airway into an emergency. Finally, COVID-19 has increased the stress experienced by healthcare providers taking care of patients with LTS, as airway procedures are often considered high risk for aerosol generation. Decisions regarding preferred airway technique (direct laryngoscope, videolaryngoscope or fiberoptic bronchoscope) and size of endotracheal tube should be made in collaboration with an interprofessional team that understands the location and severity of stenosis. 

We want to thank Dr. Sandra Panchalingam for her editorial support.

No conflicts of interest. 

Laryngeal injury and upper airway symptoms after endotracheal intubation during surgery: A systematic review and metaanalysis

Understanding variable prevalences of acute laryngeal injury post-extubation

Pediatric laryngotracheal stenosis

Predictors of posterior glottic stenosis: A multiinstitutional case-control study

Proposed grading system for subglottic stenosis based on endotracheal tube sizes. The Annals of Otology

Incidence and outcomes of acute laryngeal injury after prolonged mechanical ventilation

Acquired laryngeal and subglottic stenosis following COVID-19-Preparing for the coming deluge